Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
Clinical trial NCT03702179 · COMPLETED
Trial details
- NCT number
- NCT03702179
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-19
- Primary completion
- 2020-09-29
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.